Published in Proc Soc Exp Biol Med on January 01, 1975
Isolation of alpha 1-protease inhibitor from human normal and malignant ovarian tissue. J Clin Invest (1981) 0.77
Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. N Engl J Med (2000) 18.12
HEMOGLOBIN AND PLASMA PROTEIN : SIMULTANEOUS PRODUCTION DURING CONTINUED BLEEDING AS INFLUENCED BY AMINO ACIDS, PLASMA, HEMOGLOBIN, AND DIGESTS OF SERUM, HEMOGLOBIN, AND CASEIN. J Exp Med (1943) 4.18
TEN AMINO ACIDS ESSENTIAL FOR PLASMA PROTEIN PRODUCTION EFFECTIVE ORALLY OR INTRAVENOUSLY. J Exp Med (1943) 2.91
Exemestane is superior to megestrol acetate after tamoxifen failure in postmenopausal women with advanced breast cancer: results of a phase III randomized double-blind trial. The Exemestane Study Group. J Clin Oncol (2000) 2.73
Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk. J Clin Oncol (1998) 2.55
Granulocyte colony-stimulating factor in severe chemotherapy-induced afebrile neutropenia. N Engl J Med (1997) 2.25
Irinotecan therapy in adults with recurrent or progressive malignant glioma. J Clin Oncol (1999) 2.23
CASEIN DIGESTS PARENTERALLY UTILIZED TO FORM BLOOD PLASMA PROTEIN. J Exp Med (1941) 2.18
The molecular cloning and characterization of murine ferritin heavy chain, a tumor necrosis factor-inducible gene. J Biol Chem (1988) 2.15
Genetic screening: marvel or menace? Science (1984) 1.78
Pharmacokinetics, metabolism, and excretion of irinotecan (CPT-11) following I.V. infusion of [(14)C]CPT-11 in cancer patients. Drug Metab Dispos (2000) 1.67
Chronic ataluren (PTC124) treatment of nonsense mutation cystic fibrosis. Eur Respir J (2011) 1.63
PLASMA SUBSTITUTES : HUMAN AND ANIMAL GLOBIN RELATED TO THE PRODUCTION OF HEMOGLOBIN AND PLASMA PROTEIN DOG HEMOGLOBIN UTILIZATION IMPROVED BY METHIONINE BUT NOT BY ISOLEUCINE. J Exp Med (1946) 1.61
PERITONEAL ABSORPTION : RED CELLS LABELED BY RADIO-IRON HEMOGLOBIN MOVE PROMPTLY FROM PERITONEAL CAVITY INTO THE CIRCULATION. J Exp Med (1944) 1.55
HEMOGLOBIN AND PLASMA PROTEIN PRODUCTION : VARIOUS PROTEINS, CONCENTRATES, AND DIGESTS INFLUENCE BLOOD PROTEIN PRODUCTION IN ANEMIA AND HYPOPROTEINEMIA. J Exp Med (1946) 1.46
Thermal injury and recovery of Bacillus subtilis. Appl Microbiol (1972) 1.45
Genetic counseling for beta-thalassemia trait following health screening in a health maintenance organization: comparison of programmed and conventional counseling. Am J Hum Genet (1981) 1.44
A multicenter, phase II trial of weekly irinotecan (CPT-11) in patients with previously treated colorectal carcinoma. Cancer (1999) 1.41
RAIDING OF BODY TISSUE PROTEIN TO FORM PLASMA PROTEIN AND HEMOGLOBIN : WHAT IS PREMORTAL RISE OF URINARY NITROGEN? J Exp Med (1947) 1.40
Screening and genetic counseling for beta-thalassemia trait in a population unselected for interest: effects on knowledge and mood. Am J Hum Genet (1979) 1.39
Stopping a clinical trial very early because of toxicity: summarizing the evidence. Control Clin Trials (1993) 1.39
Newborn screening for hemoglobinopathies in New York State: experience of physicians and parents of affected children. J Pediatr (1982) 1.35
Women's receptivity to testing for a genetic susceptibility to breast cancer. Am J Public Health (1995) 1.35
PLASMA PROTEIN AND HEMOGLOBIN PRODUCTION : DELETION OF INDIVIDUAL AMINO ACIDS FROM GROWTH MIXTURE OF TEN ESSENTIAL AMINO ACIDS. SIGNIFICANT CHANGES IN URINARY NITROGEN. J Exp Med (1947) 1.34
Irinotecan plus fluorouracil/leucovorin for metastatic colorectal cancer: a new survival standard. Oncologist (2001) 1.29
PLASMA PROTEIN PRODUCTION AS INFLUENCED BY PARENTERAL PROTEIN DIGESTS, VERY HIGH PROTEIN FEEDING, AND RED BLOOD CELL CATABOLISM. J Exp Med (1945) 1.22
Cannabis: effects on memory and the cholinergic limbic system. Psychol Bull (1983) 1.19
Therapy of patients with malignant melanoma using a monoclonal antimelanoma antibody-ricin A chain immunotoxin. Cancer Res (1987) 1.18
The effect of perfusate pH on glutamine metabolism in the isolated perfused rat liver. J Biol Chem (1970) 1.18
The functional significance of changes in activity of the enzymes, tryptophan pyrrolase and tyrosine transaminase, after induction in intact rats and in the isolated, perfused rat liver. J Biol Chem (1969) 1.14
Prenatal screening for hemoglobinopathies. II. Evaluation of counseling. Am J Hum Genet (1991) 1.13
Screening and genetic counseling for beta-thalassemia trait in a population unselected for interest: comparison of three counseling methods. Am J Hum Genet (1984) 1.13
Molecular genetic analysis of tumors in von Recklinghausen neurofibromatosis: loss of heterozygosity for chromosome 17. Genes Chromosomes Cancer (1989) 1.13
A CASEIN DIGEST BY VEIN UTILIZED TO FORM BLOOD PLASMA PROTEIN. Science (1941) 1.12
Anhidrotic ectodermal dysplasia: predisposition to bronchial disease. Ann Intern Med (1971) 1.12
Insulin effects on apolipoprotein B production by normal, diabetic and treated-diabetic rat liver and cultured rat hepatocytes. Biochem J (1989) 1.11
Effect of whole x-irradiation of rats on net synthesis of albumin, fibrinogen, alpha-1-acid glycoprotein, and alpha-2-globulin (acute phase globulin) by the isolated, perfused rat liver. J Biol Chem (1968) 1.08
Induction of -globin synthesis in the -thalassaemia of Ferrara. Nat New Biol (1972) 1.08
Inducers of erythroid differentiation in K562 human leukemia cells. Exp Hematol (1981) 1.07
Erythroid colony formation from human fetal liver. Proc Natl Acad Sci U S A (1978) 1.06
Infraputaminal 'lacunes'. Clinical and pathological correlations. Stroke (1995) 1.06
Tumor necrosis factor-alpha and interleukin 1-alpha regulate transferrin receptor in human diploid fibroblasts. Relationship to the induction of ferritin heavy chain. J Biol Chem (1991) 1.06
The PREP system of nursing interventions: a pilot test with families caring for older members. Preparedness (PR), enrichment (E) and predictability (P). Res Nurs Health (1995) 1.06
Measurement of pepsin I (gastricsin) in human gastric juice. Gastroenterology (1967) 1.06
Overview of clinically significant adverse reactions to bupropion. J Clin Psychiatry (1983) 1.04
Influence of actinomycin D and puromycin on net synthesis of plasma albumin and fibrinogen by the isolated perfused rat liver. J Biol Chem (1966) 1.02
Cystic fibrosis carrier population screening in the primary care setting. Am J Hum Genet (1996) 1.02
Missing quasiparticles and the chemical potential puzzle in the doping evolution of the cuprate superconductors. Phys Rev Lett (2004) 1.02
Prenatal hemoglobinopathy screening. IV. Follow-up of women at risk for a child with a clinically significant hemoglobinopathy. Am J Hum Genet (1991) 1.01
A comparison of measures of reading and intelligence as risk factors for the development of myopia in a UK cohort of children. Br J Ophthalmol (2008) 1.00
Phase I dose-finding and pharmacokinetic trial of irinotecan hydrochloride (CPT-11) using a once-every-three-week dosing schedule for patients with advanced solid tumor malignancy. Clin Cancer Res (2000) 1.00
Newborn sickle cell screening. Benefits and burdens realized. Am J Dis Child (1983) 0.96
Studies of human intrinsic factor auto-antibodies. J Immunol (1966) 0.96
Genome-wide association study of shared components of reading disability and language impairment. Genes Brain Behav (2013) 0.95
Studies on the heterogeneity of human gastric zymogens. Biochem J (1970) 0.95
Phase I and pharmacokinetic trial of oral irinotecan administered daily for 5 days every 3 weeks in patients with solid tumors. J Clin Oncol (1999) 0.95
Genetic counseling of asymptomatic carriers in a primary care setting. The effectiveness of screening and counseling for beta-thalassemia trait. Ann Intern Med (1986) 0.94
Inhibition of interleukin-1-alpha-induced nitric oxide synthase in vascular smooth muscle and full reversal of interleukin-1-alpha-induced hypotension by N omega-amino-L-arginine. J Natl Cancer Inst (1992) 0.94
Hemoglobin synthesis in cultures of hepatic erythroid cells from the human fetus. Proc Natl Acad Sci U S A (1979) 0.94
Synthesis of clotting factors by the isolated perfused rat liver. J Clin Invest (1966) 0.93
Role of the liver in regulating somatomedin activity: hormonal effects on the synthesis and release of insulin-like growth factor and its carrier protein by the isolated perfused rat liver. Endocrinology (1979) 0.92
Cerebellomedullary ganglioglioma: CT and MR findings. AJNR Am J Neuroradiol (1995) 0.92
Severe myelosuppression resulting from concurrent administration of granulocyte colony-stimulating factor and cytotoxic chemotherapy. J Natl Cancer Inst (1992) 0.92
Phase I dose-finding and pharmacokinetic trial of irinotecan (CPT-11) administered every two weeks. Ann Oncol (2001) 0.91
Family issues in a psychoeducation group for women with a BRCA mutation. Clin Genet (2002) 0.91
Bupropion: clinical assay for amphetamine-like abuse potential. J Clin Psychiatry (1983) 0.90
The toxic and hematologic effects of interleukin-1 alpha administered in a phase I trial to patients with advanced malignancies. J Clin Oncol (1992) 0.90
Distinction between two types of beta-thalassaemia by inducibility of the cell-free synthesis of beta-chains by nonthalassaemic soluble fraction. Nat New Biol (1972) 0.89
Protein synthesis in the maturing reticulocyte. J Biol Chem (1967) 0.89
Separation of malarial parasites according to age by density gradient centrifugation. J Lab Clin Med (1967) 0.89
Phase II study of irinotecan plus cisplatin in patients with advanced non-small-cell lung cancer. J Clin Oncol (1999) 0.89
Spontaneous palpebromandibular synkinesia: a localizing clinical sign. Ann Neurol (1994) 0.89
Effect of 9 -THC on the open-field activity of the rat. Psychopharmacologia (1972) 0.88
A phase II study of irinotecan with 5-fluorouracil and leucovorin in patients with previously untreated gastric adenocarcinoma. Ann Oncol (2001) 0.88
Multipotent human hematopoietic cell line K562: lineage-specific constitutive and inducible antigens. Leuk Res (1987) 0.88
Caries-preventive effects of sodium and amine fluoride dentifrices. Am J Dent (1999) 0.87
Marijuana and memory impairment: effect on free recall and recognition memory. Pharmacol Biochem Behav (1977) 0.87
Newborn screening for sicle-cell disease. Benefits and burdens. N Y State J Med (1978) 0.86
Protein synthesis in reticulocytes maturing in vivo. Nature (1965) 0.86
The neurofibroma in von Recklinghausen neurofibromatosis has a unicellular origin. Am J Hum Genet (1991) 0.86
Carrier screening for cystic fibrosis: test acceptance and one year follow-up. Am J Med Genet (1997) 0.86
Prominence of coronary arterial wall lipids in human heart allografts. Implications for pathogenesis of allograft arteriopathy. Am J Pathol (1995) 0.86
GELATIN-ITS USEFULNESS AND TOXICITY : BLOOD PROTEIN PRODUCTION IMPAIRED BY CONTINUED GELATIN BY VEIN. J Exp Med (1944) 0.86
Erythroleukemia manifesting delta beta-thalassemia. Hemoglobin (1983) 0.85
Pepstatin-insensitive proteolytic activity of rat liver lysosomes. Isolation and purification of a new pepstatin-insensitive proteolytic enzyme from rat liver lysosomes. J Biol Chem (1977) 0.85
Pathogenesis of deficient serum alpha1-antitrypsin in the type ZZ homozygote. Biochem Genet (1974) 0.85
An adult homozygous for persistent fetal hemoglobin. Ann Intern Med (1970) 0.85
Critical adjustment of cysteine and glutamine concentrations for improved clonal growth of WI-38 cells. In Vitro (1977) 0.85
Alveolar cell carcinoma in identical twins. Similarity in time of onset, histochemistry, and site of metastasis. Ann Intern Med (1977) 0.85
Effect of aging on animal response to chronic fluoride exposure. J Dent Res (1995) 0.84
Pathology of small artery disease. Adv Neurol (1993) 0.84
A Lepore hemoglobin in a Rumanian family. Hum Hered (1969) 0.84
Regulation of K562 cell transferrin receptors by exogenous iron. J Cell Physiol (1985) 0.84
Sickle hemoglobin: a specific radioimmunoassay. Blood (1974) 0.84
The diagnosis of beta-thalassemia trait: a review. Am J Hematol (1976) 0.84
Relationship between plasma delta-9-tetrahydrocannabinol concentration and pharmacologic effects in man. Psychopharmacology (Berl) (1981) 0.84
Linkage between the MN- and Hb beta-loci? Hum Hered (1972) 0.84